IL‐2 receptor antagonist induction vs no antibody induction
All‐cause mortality · lung transplant recipients
IL‐2 receptor antagonist induction showed no clear difference in mortality compared with no antibody induction (moderate certainty).
1 finding from 1 review
- RR 0.67 [0.22, 2.07]1 study · 25 participantsModerate